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Abstract Cupiennin 1a, a cytolytic peptide isolated from
the venom of the spider Cupiennius salei, exhibits broad
membranolytic activity towards bacteria, trypanosomes,
and plasmodia, as well as human blood and cancer cells. In
analysing the cytolytic activity of synthesised all-D- and
all-L-cupiennin 1a towards pro- and eukaryotic cells, a
stereospecific mode of membrane destruction could be
excluded. The importance of negatively charged sialic
acids on the outer leaflet of erythrocytes for the binding and
haemolytic activity of L-cupiennin 1a was demonstrated.
Reducing the overall negative charges of erythrocytes by
partially removing their sialic acids or by protecting them
with tri- or pentalysine results in reduced haemolytic
activity of the peptide.
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Introduction
The hunting success of the Central American spider
Cupiennius salei (Ctenidae) strongly depends on the power
of its chelicerae and the paralysing/killing effect of its
venom. The venom is characterised by proteins, low
molecular mass compounds and peptides. Beside neuro-
toxins and enhancer peptides, about one-third of the venom
consists of small cysteine-free peptides, the cupiennins
(Kuhn-Nentwig et al. 2002b) which are also named
M-ctenitoxin-Cs1a-1d according to a newly proposed toxin
nomenclature (ArachnoServer spider toxin database
http://www.arachnoserver.org/). These a-helical peptides
are highly cationic and exhibit strong cytolytic activities
towards different prokaryotic cells and human erythrocytes
(Kuhn-Nentwig et al. 2002b). A dual role is proposed
for cupiennins in that: (1) due to their cytolytic activity
they synergistically enhance the activity of neurotoxins
and other venom peptides (Kuhn-Nentwig et al. 2004;
Wullschleger et al. 2004, 2005) and (2) they protect che-
licerae and venom glands against microbial infections
(Kuhn-Nentwig 2003). The best investigated cytolytic
peptide, cupiennin 1a, is characterised by a helix–hinge–helix
structure (Pukala et al. 2007a), comparable to the structure
of latarcin 2a (M-zodatoxin-Lt2a), a cytolytic peptide
isolated from the venom of the central Asian spider
Lachesana tarabaevi (Zodariidae) (Kozlov et al. 2006). As
a linear cationic peptide, cupiennin 1a adopts a-helical
conformation in the presence of negatively charged mem-
branes and is attracted to the membrane by electrostatic
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interactions. 31P solid-state nuclear magnetic resonance
(NMR) spectroscopy of different phospholipid bilayers
with cupiennin 1a (Cu1a) points to a possible toroidal pore
formation as the mechanistic basis of its antimicrobial
effect (Pukala et al. 2007a). Remarkably, Cu1a exhibits a
second, non-membranolytic activity: in the submicromolar
range, the peptide inhibits the formation of nitric oxide by
neuronal nitric oxide synthase through complexation with
the regulatory protein Ca2? calmodulin (Pukala et al.
2007b). This indicates that the targets of Cu1a in a spider’s
prey are not only the cell membranes, but also cellular
enzymes. Their inhibition, in combination with pore for-
mation by Cu1a, together with the action of other venom
compounds leads to the rapid destruction of vitally
important systems.
Investigations concerning the antimicrobial activity of
all-D and all-L enantiomers of several host defence
peptides revealed that all-D enantiomers have the same
or even improved antimicrobial activity due to slower
enzymatic inactivation than natural all-L enantiomers
(Bessalle et al. 1990; Jung et al. 2007; Kitani et al. 2009;
Li et al. 2000; Ma¨ntyla¨ et al. 2005; McGwire et al. 2003;
Thevissen et al. 2005; Vunnam et al. 1998; Wade et al.
1990; 2000), indicating a chirally independent mecha-
nism of membrane disruption. Nevertheless, a dual mode
of action is reported for a proline-rich antibacterial
peptide, cathelicidin Bac7: a stereospecificity-dependent
uptake and binding to an intracellular target at near-
MIC concentrations and a non-stereoselective mem-
brane disruption at higher concentrations (Podda et al.
2006).
To exclude a stereospecific cytolytic effect of all-D-
cupiennin 1a (D-Cu1a) and all-L-cupiennin 1a (L-Cu1a),
we performed bioassays with bacteria, trypanosomes,
human erythrocytes and Drosophila melanogaster. Since
we did not detect any stereospecificity, we tested the
cytolytic activity of only L-Cu1a towards Plasmodium
falciparum and different human blood cells as well as
leukemic and tumour cells. To explore the membrane-
specific mode of action of L-Cu1a, we also analysed
the involvement of sialic acids in the haemolytic
activity of L-Cu1a by protection or partial removal of
these groups.
Materials and methods
Peptides
C-terminal amidated all-L- (L-Cu1a) and all-D-cupiennin 1a
(D-Cu1a) were synthesised by BACHEM AG (Bubendorf,
Switzerland). Trilysine, pentalysine and neuraminidase
were purchased from Sigma–Aldrich (Buchs, Switzerland).
Antimicrobial assays
Escherichia coli ATCC 25 922 and Staphylococcus aureus
ATCC 29213 were cultured in Mueller–Hinton broth. The
bactericidal activity of the peptides was determined using a
microtiter broth dilution assay (Wu and Hancock 1999).
The bacterial inoculum prepared from mid log phase
cultures was diluted to a final concentration of
*3.7 9 105 cfu/ml. Twofold dilution of peptides (L-Cu1a
or D-Cu1a: 0.04–2.5 lM), non-treated growth control and a
sterility control were tested sixfold as described earlier
(Kuhn-Nentwig et al. 2002b). Cell growth was estimated
by monitoring the optical density at 630 nm and the
resulting colony forming units were counted after 18 h of
incubation at 37C.
Trypanosoma brucei brucei MiTat1.2(221) were cul-
tured in HMI-9 medium (Hesse et al. 1995) supplemented
with 10% (v/v) FCS at 37C in a 5% CO2 atmosphere in
25 cm2 tissue culture flasks. For toxin assays, cells were
seeded into 96-well microtiter plates (100 ll/well,
1 9 104 cells/well). Serial peptide dilutions were added in
triplicate (5 ll/well), and plates were incubated for 68–
72 h at 37C in a 5% CO2 atmosphere. At the end of this
period, 10 ll/well of resazurin (Sigma R7017; 0.5 mM in
PBS) were added, and incubation was continued for an
additional 2 h before fluorescence was determined (Ra¨z
et al. 1997) (excitation at 536 nm, emission at 588 nm).
In vitro assays for detection of antiprotozoal activity
against Plasmodium falciparum (K1 strain resistant to
chloroquine and pyrimethamine), Trypanosoma brucei
rhodesiense (bloodstream forms), and Trypanosoma cruzi
(intracellular amastigotes in L-6 rat skeletal myoblasts)
were carried out in duplicate as reported previously
(Ganapaty et al. 2006).
Cytotoxicity against L-6 cells
Cytotoxicity assay was performed in a 96-well microtiter
plate in duplicate, each well containing 100 ll of RPMI
1640 medium supplemented with 1% L-glutamine
(200 mM) and 10% foetal bovine serum, and 4 9 104 L-6
cells (a primary cell line derived from rat skeletal myo-
blasts). Serial L-Cu1a dilutions of seven threefold dilution
steps covering a range from 90 to 0.123 lg/ml were pre-
pared. After 72 h of incubation the plate was inspected
under an inverted microscope to assure growth of the
controls and sterile conditions. Subsequently, Alamar blue
(10 ll) was added to each well and the plate incubated for
another 2 h. The plates were then read with a Spectramax
Gemini XS microplate fluorometer using an excitation
wavelength of 536 nm and an emission wavelength of
588 nm (Ra¨z et al. 1997). Data were analysed using the
microplate reader software Softmax Pro.
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Insecticidal activity
Drosophila melanogaster were used to determine the
insecticidal activity of the peptides. Eleven (L-Cu1a) and
nine (D-Cu1a) different peptide concentrations between 1.5
and 29.3 pmol/mg fly (injected in a total volume of 0.05 ll
of insect ringer) were tested on each of 20 flies and 20
flies were used as controls (0.05 ll of insect ringer only).
Calculations of the lethal doses LD50 (50% of the test flies
died of intoxication 24 h post-injection) were performed as
described elsewhere (Kuhn-Nentwig et al. 2000).
Haemolytic activity
Peptide (L-Cu1a or D-Cu1a; 0.2–50 lM) induced haemol-
ysis (incubation for 1 h at 37C) was determined using
fresh human red blood cells (2.4 9 108 cells/ml). Release
of haemoglobin was monitored by changes in the absor-
bance at 541 nm (Jasco V-550, Japan). The positive control
(100% haemolysis) was human erythrocytes in distilled
water and the negative control (0% haemolysis) was human
erythrocytes in phosphate-buffered saline as described in
(Kuhn-Nentwig et al. 2002b).
Protection experiments with tri- or penta-lysine
The haemolytic activity of 2.5 lM L-Cu1a was determined
in the presence of increasing concentrations of trilysine or
pentalysine. Erythrocytes (1.7 9 108 cells/ml) were pre-
incubated for 10 min with trilysine (0.1–1 mM) or pen-
talysine (0.1–0.5 mM) at 25C in 230 ll of PBS A (5 mM
NaH2PO4 9 H2O, 150 mM NaCl, pH 7.2). After adding
20 ll L-Cu1a, the erythrocytes were further incubated for
1 h at 37C. The percentage of haemolysis was calculated
as mentioned above.
Sialic acid depletion of erythrocytes
Human erythrocytes (20% haematocrit) were incubated
with neuraminidase (Clostridium perfringens Type V,
Sigma, 1–80 lg/ml) in PBS B (5 mM NaH2PO4 9 H2O,
150 mM NaCl, 0.5 mM CaCl2 9 2H2O, pH 7.2) for 1 h at
37C. Determination of released sialic acids was done with
the resorcinol/FeCl3 method as described (Reuter and
Schauer 1994) and a calibration curve was generated with
sialic acid (N-acetylneuraminic acid, Type IV-S, Sigma) in
a concentration range from 1 to 10 lg. Then, sialic acid
depleted erythrocytes were washed four times with PBS A
and diluted to 1.6 9 107 cells/ml. Erythrocytes were
incubated with L-Cu1a (5.4 lM) for 1 h at 37C and
haemolysis was determined as described above.
LDH assay of human blood and cancer cells
Erythrocytes, lymphocytes, and granulocytes were
obtained from anticoagulated human blood from healthy
volunteers as described earlier (Willems et al. 2002).
Various human cancer cells were obtained from the Rega
Institute (K.U. Leuven, Belgium). Human tumour cells
were cultured in RPMI-1640 medium, supplemented with
10% foetal calf serum, 2 mM glutamine, penicillin (100 U/
ml) and streptomycin (100 lg/ml) at 37C, 5% CO2 and
95% relative humidity. Cells were washed with phosphate-
buffered saline (PBS) buffer and directly used except for
HEK, HEK/SV40 and HeLa cells, which were harvested
after trypsinization and then washed with PBS buffer.
For the lactate dehydrogenase assay (LDH assay),
human granulocytes, lymphocytes, erythrocytes and
diverse cancer cells (4–6 9 106 cells/ml) were incubated
with different concentrations of L-Cu1a in 300 ll of PBS
buffer for 20 min at 37C. Afterwards, the samples were
centrifuged and 100 ll supernatant was used in the LDH
assay with pyruvate as substrate and NADH as coenzyme,
and measured at 340 nm as described (Bergmeyer and
Bernt 1974).
Granulocytes and activation assays
Inhibition of superoxide production by NADPH oxidase
activity was measured as follows. Granulocytes were
diluted to a final concentration of 2 9 105/ml. Lyophilized
L-Cu1a (60 lg/50 ll) was dissolved in water and added to
300 ll of granulocyte suspension to obtain a final con-
centration of 2 9 10-7 and 5 9 10-7 M of L-Cu1a. After
incubation for 1 h at 37C, 50 ll lucigenin (0.5 mg/ml)
was added and the background chemiluminescence was
measured. Then 50 ll phorbol myristate acetate (PMA,
1 lg/ml) was added and superoxide production was mea-
sured for 10–15 min using a Biolumat 9505 (Berthold,
Germany) apparatus. Peak luminescence values were
compared and inhibition was calculated as a percentage of
superoxide production produced by PMA in control sam-
ples (no cytolytic peptide present).
The chemotaxis assay was performed using 24-well
plates (Transwell-Costar, pore size 3 mm). Upper wells
(200 ml) contained granulocytes (±106/ml), and lower
wells (400 ll) L-Cu1a or control. At the end of the 1 h
experiment (at 37C) a cell sample was taken from both
compartments and counted. The migration ratio was cal-
culated. Both negative (no L-Cu1a) and positive controls
(formylated tripeptide fMLP, 3 9 10-8 M) were included
and results expressed in relation to the value for fMLP
(set = 100%).
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The human cells (leucocytes and erythrocytes) were
obtained after informed consent according to the ethical
guidelines of the K.U. Leuven, Belgium, and the guidelines
for researcher of the University Bern, Switzerland.
For statistics, the peptide concentrations at which 50%
haemolysis, cell growth inhibition or inhibition of cell
viability was observed (EC50; IC50) were derived using
sigmoidal curve fitting software (GraphPad Prism 4.0,
Graph Pad Software).
Results and discussion
Cytolytic activity of D-Cu1a and L-Cu1a enantiomers
on trypanosomes, bacteria, human erythrocytes
and insects
The cytolytic activity of different concentrations of
D-Cu1a and L-Cu1a on diverse membrane types is mostly
within a comparable submicromolar range (Fig. 1). The
trypanocidal activity of the enantiomers exhibits no major
differences, with an IC50 of 0.136 lM for D-Cu1a and
0.120 lM for L-Cu1a (Fig. 1a). The microscopically
observed minimal inhibition concentrations (MIC) for both
peptides were estimated at 0.328 lM for T. brucei 221. In
addition, no differences are visible in their haemolytic
activity (Fig. 1b), with an EC50 of 3.32 lM (D-Cu1a) and
3.10 lM (L-Cu1a). However, the bactericidal activity of D-
Cu1a (IC50 0.375 lM) towards E. coli was twofold higher
than determined for the L-variant (IC50 0.774 lM),
and towards S. aureus threefold higher for the D-variant
(IC50 0.119 lM) than for the L-variant (IC50 0.383 lM)
(Fig. 1 c, d). Both enantiomers were similarly active
against E. coli (IC50 = 0.63–1.25 lM), but showed slightly
different activities against S. aureus (L-Cu1a: 0.63–
1.25 lM; D-Cu1a: 0.32–0.63 lM). As to the insecticidal
activity, the L-variant is about twofold less potent than
D-Cu1a (LD50 2.9 pmol/mg fly), with an LD50 of 6.8 pmol/
mg fly. To explain these small differences in the activity
of D-Cu1a towards bacteria and D. melanogaster we note
Fig. 1 Cytolytic activity of D- and L-enantiomers of Cu1a towards
trypanosomes, human erythrocytes and bacteria. a Trypanosomes
(105 cells/ml; bloodstream form) were incubated for 72 h at 37C
with twofold dilution steps of D-Cu1a and L-Cu1a (highest peptide
concentration 2.63 lM). Cell viability was monitored with the
Alamar blue assay and fluorescence was measured with excitation
at 536 nm and emission at 588 nm. b Human erythrocytes
(2.4 9 108 cells/ml) were incubated for 1 h at 37C with different
concentrations of D-Cu1a and L-Cu1a (0.2–50 lM) and haemolysis
was measured at 541 nm. (c and d) The bactericidal activity of D-
Cu1a and L-Cu1a (0.04–100 lM) towards E. coli and S. aureus
(*3.7 9 105 cfu/ml) was determined with the microtiter broth
dilution assay. Cell growth was estimated by monitoring optical
density at 630 nm and counting the resulting colony forming units
after 18 h of incubation at 37C
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that D-enantiomers are more resistant to degradation by
proteases, which could be released into the media by
bacteria and are present in flies after peptides injection due
to tissue damage (Alvarez-Bravo et al. 1994; Bessalle et al.
1990; Vunnam et al. 1998). In the case of bacteria, both
enantiomers are attracted by negatively charged phospho-
lipids and lipopolysaccharides on the highly negatively
charged outer membrane surfaces, resulting in a-helical
conformation of the peptide and subsequent membrane
disruption in a non-stereospecific manner. The cell surface
of the bloodstream form of T. brucei is characterised by a
dense monolayer of homodimers of surface glycoproteins
(VSG) of approximately 15 nm thickness, which is net
neutral at pH 8 (M.A. Ferguson, personal communication)
(Mehlert et al. 1998). The VSG layer acts as a macromo-
lecular diffusion barrier only for molecules above 20 kDa
(Mehlert et al. 2002). Remarkably, the plasma membrane
of T. brucei exhibits a very high cholesterol/phospholipid
ratio of 1.54 (Voorheis et al. 1979) but it has also a high
content of negatively charged phosphatidylserine and
phosphatidylinositol. This could allow the enantiomers to
electrostatically interact with the cell membrane, thus inducing
severe damage as has been reported for insect defensin-derived
synthetic peptides (Kitani et al. 2009; Patnaik et al. 1993). In
addition, a high content of lipid-bound sialic acid residues have
been determined for bloodstream forms of T. brucei brucei
(Carroll and McCrorie 1986). These might also contribute to
the electrostatic attraction of the peptides. Incubation of
T. brucei with melittin, a cytolytic peptide isolated from honey
bee venom in submicromolar concentrations, resulted in a
calcium influx into the parasites without disrupting cell per-
meability, which only occurs at higher concentrations (Ruben
et al. 1996). Our results also support other reports concerning
the trypanocidal activity of several antimicrobially acting
peptides of diverse origin which act by disrupting membrane
integrity (Boulanger et al. 2002; Kitani et al. 2009; Lo¨fgren
et al. 2008; McGwire et al. 2003; Yamage et al. 2009).
Due to the fact that no stereospecific effects of Cu1a-
enantiomers on diverse membrane types could be demon-
strated, the susceptibility of three further pathogenic eukary-
otic parasites was investigated only with L-Cu1a. All three
parasites, T. brucei rhodesiense (sleeping sickness), T. cruzi
(Chagas’ disease) and P. falciparum (malaria tropica) are
sensitive to the peptide in the submicromolar range (Table 1).
Unexpectedly, rat skeletal myoblasts (L-6 cells), used as a
control for cytotoxicity, exhibit an IC50 of 0.342 lM; thus,
these myoblasts are up to three times more sensitive than
T. cruzi. The high susceptibility of L-6 cells towards L-Cu1a
could possibly be explained by the presence of sialic acids on
the cell surface (De Bank et al. 2003), which could be
responsible for membrane binding and lysis by L-Cu1a.
The attraction of antimicrobial peptides due to negative
charges of diverse bacterial membrane structures
(lipopolysaccharides, phosphatidylglycerol, diphosphat-
idylglycerol) is beyond doubt, whereas the binding of
cytolytic and antimicrobial peptides and subsequent cell
membrane damage of erythrocytes are still poorly under-
stood (Lohner 2001). In the cytotoxicity standard test of
antimicrobial peptides towards eukaryotic cells, erythro-
cytes are mainly used because they are abundant and easy
to isolate. Human erythrocytes are characterised by an
asymmetric distribution of phospholipids in its membrane.
Negatively charged phosphatidylserine is located only in
the inner leaflet, whereas the outer leaflet is composed of
sphingomyelin, phosphatidylcholine, phosphatidylethanol-
amine and cholesterol (Verkleij et al. 1973). The overall
negative charge of the erythrocytes is reduced to different
carbohydrate structures containing sialic acids (Viitala and
Ja¨rnefelt 1985). Thus, a possible role for sialic acids as a
factor which regulates the haemolytic activity of L-Cu1a
could be tested by modifying human erythrocytes. Sub-
sequent removal of sialic acid from the surface of human
erythrocytes results in a *20% reduction of haemolysis
caused by L-Cu1a, as demonstrated in Fig. 2. In addition,
reducing the overall negative charge of the human eryth-
rocyte surface by application of increasing concentrations
of trilysine and pentalysine before incubation with L-Cu1a,
strongly reduces the haemolytic activity of cytolytic pep-
tide (Fig. 3). These combined observations point to the
impact of the total surface charge of erythrocytes. In this
experiment 29-h-old erythrocytes were used, which exhibit
a higher susceptibility to L-Cu1a (2.5 lM L-Cu1a causes
*90% haemolysis) than fresh erythrocytes (2.5 lM L-
Cu1a causes *40% haemolysis). It seems that the nega-
tively charged sialic acids on the cell surface of erythro-
cytes enable L-Cu1a to adopt an a-helical conformation,
resulting in membrane binding by electrostatic attraction.
In spite of lacking negatively charged phospholipids in the
outer membrane, damage to the cell membrane occurs by
insertion of the hydrophobic N-terminal part of L-Cu1a via
Table 1 Cytolytic effects of L-Cu1a on protozoan parasites with IC50
inhibitory concentrations of two independent assays (A and B)
Cell type Cells/ml IC50 (lM)
A B
Eukaryotic parasites
Trypanosoma brucei
rhodesiense
1.0 9 105 0.055 0.061
Trypanosoma cruzi 5.0 9 104 0.658 1.182
Plasmodium falciparum 2.5% haematocrit
(0.3% parasitaemia)
0.029 0.034
Eukaryotic control cell
Rat skeletal myoblasts
(L-6 cells)
4.0 9 105 0.342 0.342
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a chirally independent mechanism (Kuhn-Nentwig et al.
2002a; Pukala et al. 2007a).
Effects of L-Cu1a on different human cells
The cytolytic effect of L-Cu1a on different normal human
blood cells, leukemic and tumour cells exhibits consider-
able differences (Table 2). Considering lytic activity,
granulocytes and lymphocytes are about 40–50 times
more sensitive to L-Cu1a compared with human erythro-
cytes (EC50 23 lM). The production of superoxide by the
NADPH oxidase in PMA stimulated granulocytes is
inhibited to 90% (99%) in the presence of 0.2 lM (0.5 lM)
L-Cu1a. This inhibition occurs in about the same concen-
tration range as reported for parabutoporin and opistoporin,
cationic pore forming peptides isolated from the venom of
South African scorpions (Willems et al. 2002, 2004). The
latter are also chemotactic for granulocytes but, in contrast
to these results, no induction of a granulocyte chemotactic
response could be observed with L-Cu1a in concentrations
between 0.2 and 0.8 lM.
Furthermore, different human leukemic cell lines are
66–121 times more sensitive to L-Cu1a than human
erythrocytes. Among the human tumour cells tested, HeLa
are the most sensitive (EC50 of 0.15 lM). Interestingly,
HEK 293 tumour cells are about 2.9-fold more sensitive to
the peptide than HEK 293-T cells. The latter cell line
differs from HEK 293 in that it expresses, in rafts on the
cell membrane, SV40 large T antigen. This protein con-
tains many lysine and arginine residues at critical places
(Henning and Lange-Mutschler 1983; Walser et al. 1989).
The reduction of the overall negative charge of the cells by
the positively charged amino acids could lower the binding
possibilities for L-Cu1a, resulting in less sensitive HEK
293-T cells. A comparable charge-dependent targeting of
cationic dextran to different tumour cell lines is proposed
in which the compound binds to sialic acid residues of
different cancer cells, resulting in membrane disturbance
and subsequently cell death (Ma´rquez et al. 2004). In
general, cancer cells are characterised by a higher content
of phosphatidylserine, increased levels of sialic acids on
the outer leaflet and high negative transmembrane poten-
tials, which could allow interaction between the cells and
antimicrobial/cytolytic peptides (Dennison et al. 2006).
Fig. 2 Partial sialic acid depletion of human erythrocytes reduces the
cytolytic activity of L-Cu1a. Sialic acids were removed from fresh
erythrocytes (20% hematocrit) by incubation with different concen-
trations of neuraminidase. Afterwards, erythrocytes (*1.6 9
107 cells/ml) were incubated with 5.4 lM L-Cu1a for 1 h at 37C
and haemolytic activity was measured at 541 nm
Fig. 3 Preincubation of human erythrocytes with different concen-
trations of trilysine or pentalysine reduces the cytolytic activity of L-
Cu1a. Here, 29-h-old erythrocytes (*1.7 9 108 cells/ml) were
preincubated for 10 min at 25C with different concentrations of tri- or
penta-lysine. After incubation with 2.5 lM L-Cu1a for 1 h at 37C
haemolytic activity was measured as change in the absorbance at 541 nm
Table 2 Effect of L-Cu1a on different human cells and cell lines
Cell type
(4–6 9 106 cells/ml)
EC50 (lM) 95% confidence
intervals
Human blood cells
Erythrocytes 23.0 17.2–30.9
Granulocytes 0.47 0.44–0.50
Lymphocytes 0.56 0.54–0.60
Human leukemic cells
Raji 0.19 0.16–0.23
HL-60 0.23 0.20–0.25
Sup T1 0.23 0.16–0.32
Molt 4 0.33 0.30–0.36
THP-1 0.35 0.30–0.41
Human tumour cells
HeLa 0.15 0.13–0.17
HEK 0.16 0.14–0.19
HEK/SV40 0.46 0.41–0.53
EC50 The effective dose for 50% cell death
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Conclusions
Invertebrate host defence peptides are potentially active
against a large variety of microorganisms, but are non- to
low-toxic for vertebrate cells. In contrast, some cytolytic
and antimicrobial peptides isolated from different venom
sources, e.g. cupiennins or melittin, are able to destroy a
great variety of cell types, including eukaryotic cells like
myoblasts, and various blood and cancer cells. The
molecular basis for this discrimination (host defence pep-
tides) or non-discrimination (cytolytic peptides) is still
poorly understood (Hoskin and Ramamoorthy 2008). The
results presented here suggest that besides negatively
charged phospholipids of the target cells, the overall neg-
ative charge as mediated by different acidic compounds of
the cell membranes (sialic acids in the case of erythrocytes,
myoblasts, or leukemic cancer cells) contributes to their
susceptibility to L-Cu1a. As previously reported, L-Cu1a
exhibits strong synergistic effects on the neurotoxic activ-
ity of different neurotoxins (Kuhn-Nentwig et al. 2004;
Wullschleger et al. 2005). In the case of insects, muscle
cells as well as nerves are encircled by basement mem-
branes rich in acidic proteins such as glutactin and papilin;
glia cells are enriched with negatively charged arthrosides
(Kramerova et al. 2000; Olson et al. 1990; Sickmann et al.
1992). Destroying these negatively charged membranes by
diverse cupiennins could result in better access to their
targets for the neurotoxins, e.g. different ion channels.
With respect to the occurrence of different negatively
charged cell structures in mammals (basement membranes,
nervous tissues, internal surface of normal blood vessels,
etc.), Cu1a as a ‘‘cytolytic all-rounder’’ is not suitable for
the development of new antibiotics. Nevertheless, an
understanding of the molecular basis for this broad cyto-
lytic activity and unwanted cytotoxic activity of antimi-
crobial peptides on negatively charged cells and tissue
types in mammals is very important in the development of
new antibiotics.
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